{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:23:14Z","timestamp":1792740194597,"version":"4.5.0"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s00401-009-0560-x","type":"journal-article","created":{"date-parts":[[2009,7,13]],"date-time":"2009-07-13T11:10:13Z","timestamp":1247483413000},"page":"329-347","source":"Crossref","is-referenced-by-count":170,"title":["The ubiquitin proteasome system in neuropathology"],"prefix":"10.1007","volume":"118","author":[{"given":"Norman L.","family":"Lehman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,14]]},"reference":[{"key":"560_CR1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nature04256","volume":"438","author":"E Allen","year":"2005","unstructured":"Allen E, Ding J, Wang W et al (2005) Gigaxonin-controlled degradation of MAP1B light chain is critical to neuronal survival. Nature 438:224\u2013228","journal-title":"Nature"},{"key":"560_CR2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1471-4159.2004.02485.x","volume":"90","author":"HC Ardley","year":"2004","unstructured":"Ardley HC, Scott GB, Rose SA, Tan NG, Robinson PA (2004) UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson\u2019s disease. J Neurochem 90:379\u2013391","journal-title":"J Neurochem"},{"key":"560_CR3","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","volume":"431","author":"M Arrasate","year":"2004","unstructured":"Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431:805\u2013810","journal-title":"Nature"},{"key":"560_CR4","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nature06022","volume":"448","author":"EJ Bennett","year":"2007","unstructured":"Bennett EJ, Shaler TA, Woodman B et al (2007) Global changes to the ubiquitin system in Huntington\u2019s disease. Nature 448:704\u2013708","journal-title":"Nature"},{"key":"560_CR5","doi-asserted-by":"crossref","first-page":"32026","DOI":"10.1074\/jbc.M506084200","volume":"280","author":"SJ Berke","year":"2005","unstructured":"Berke SJ, Chai Y, Marrs GL, Wen H, Paulson HL (2005) Defining the role of ubiquitin-interacting motifs in the polyglutamine disease protein, ataxin-3. J Biol Chem 280:32026\u201332034","journal-title":"J Biol Chem"},{"key":"560_CR6","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1523\/JNEUROSCI.0800-08.2008","volume":"28","author":"B Boland","year":"2008","unstructured":"Boland B, Kumar A, Lee S et al (2008) Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer\u2019s disease. J Neurosci 28:6926\u20136937","journal-title":"J Neurosci"},{"key":"560_CR7","doi-asserted-by":"crossref","first-page":"10094","DOI":"10.1158\/0008-5472.CAN-08-1569","volume":"68","author":"CJ Braun","year":"2008","unstructured":"Braun CJ, Zhang X, Savelyeva I et al (2008) p53-Responsive microRNAs 192 and 215 are capable of inducing cell cycle arrest. Cancer Res 68:10094\u201310104","journal-title":"Cancer Res"},{"key":"560_CR8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0962-8924(02)02269-9","volume":"12","author":"A Buchberger","year":"2002","unstructured":"Buchberger A (2002) From UBA to UBX: new words in the ubiquitin vocabulary. Trends Cell Biol 12:216\u2013221","journal-title":"Trends Cell Biol"},{"key":"560_CR9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00401-005-1004-x","volume":"109","author":"R Buslei","year":"2005","unstructured":"Buslei R, Nolde M, Hofmann B et al (2005) Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol 109:589\u2013597","journal-title":"Acta Neuropathol"},{"key":"560_CR10","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1158\/1541-7786.MCR-06-0182","volume":"4","author":"C Chen","year":"2006","unstructured":"Chen C, Seth AK, Aplin AE (2006) Genetic and expression aberrations of E3 ubiquitin ligases in human breast cancer. Mol Cancer Res 4:695\u2013707","journal-title":"Mol Cancer Res"},{"key":"560_CR11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1083\/jcb.200304003","volume":"163","author":"Y Chen","year":"2003","unstructured":"Chen Y, Liu W, McPhie DL, Hassinger L, Neve RL (2003) APP-BP1 mediates APP-induced apoptosis and DNA synthesis and is increased in Alzheimer\u2019s disease brain. J Cell Biol 163:27\u201333","journal-title":"J Cell Biol"},{"key":"560_CR12","doi-asserted-by":"crossref","first-page":"8929","DOI":"10.1074\/jbc.275.12.8929","volume":"275","author":"Y Chen","year":"2000","unstructured":"Chen Y, McPhie DL, Hirschberg J, Neve RL (2000) The amyloid precursor protein-binding protein APP-BP1 drives the cell cycle through the S-M checkpoint and causes apoptosis in neurons. J Biol Chem 275:8929\u20138935","journal-title":"J Biol Chem"},{"key":"560_CR13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1126\/science.1074192","volume":"297","author":"A Chenn","year":"2002","unstructured":"Chenn A, Walsh CA (2002) Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science 297:365\u2013369","journal-title":"Science"},{"key":"560_CR14","doi-asserted-by":"crossref","first-page":"11339","DOI":"10.1074\/jbc.271.19.11339","volume":"271","author":"N Chow","year":"1996","unstructured":"Chow N, Korenberg JR, Chen XN, Neve RL (1996) APP-BP1, a novel protein that binds to the carboxyl-terminal region of the amyloid precursor protein. J Biol Chem 271:11339\u201311346","journal-title":"J Biol Chem"},{"key":"560_CR15","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/modpathol.3880072","volume":"13","author":"CT Chu","year":"2000","unstructured":"Chu CT, Caruso JL, Cummings TJ, Ervin J, Rosenberg C, Hulette CM (2000) Ubiquitin immunochemistry as a diagnostic aid for community pathologists evaluating patients who have dementia. Mod Pathol 13:420\u2013426","journal-title":"Mod Pathol"},{"key":"560_CR16","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/hmg\/ddp044","volume":"18","author":"DW Cleveland","year":"2009","unstructured":"Cleveland DW, Yamanaka K, Bomont P (2009) Gigaxonin controls vimentin organization through a tubulin chaperone-independent pathway. Hum Mol Genet 18:1384\u20131394","journal-title":"Hum Mol Genet"},{"key":"560_CR17","doi-asserted-by":"crossref","first-page":"25733","DOI":"10.1074\/jbc.M002740200","volume":"275","author":"ME Cockman","year":"2000","unstructured":"Cockman ME, Masson N, Mole DR et al (2000) Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel\u2013Lindau tumor suppressor protein. J Biol Chem 275:25733\u201325741","journal-title":"J Biol Chem"},{"key":"560_CR18","doi-asserted-by":"crossref","first-page":"24315","DOI":"10.1016\/S0021-9258(18)35767-3","volume":"267","author":"JC Cook","year":"1992","unstructured":"Cook JC, Chock PB (1992) Isoforms of mammalian ubiquitin-activating enzyme. J Biol Chem 267:24315\u201324321","journal-title":"J Biol Chem"},{"key":"560_CR19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc1819","volume":"6","author":"M Cully","year":"2006","unstructured":"Cully M, You H, Levine AJ, Mak TW (2006) Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 6:184\u2013192","journal-title":"Nat Rev Cancer"},{"key":"560_CR20","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1042\/BJ20081793","volume":"418","author":"A Cuesta","year":"2009","unstructured":"Cuesta A, Zambrano A, Royo M, Pascual A (2009) The tumour suppressor p53 regulates the expression of amyloid precursor protein (APP). Biochem J 418:643\u2013650","journal-title":"Biochem J"},{"key":"560_CR21","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1074\/jbc.M805871200","volume":"284","author":"S Dayal","year":"2009","unstructured":"Dayal S, Sparks A, Jacob J, Allende-Vega N, Lane DP, Saville MK (2009) Suppression of the deubiquitinating enzyme USP5 causes the accumulation of unanchored polyubiquitin and the activation of p53. J Biol Chem 284:5030\u20135041","journal-title":"J Biol Chem"},{"key":"560_CR22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/path.1283","volume":"199","author":"A Dil Kuazi","year":"2003","unstructured":"Dil Kuazi A, Kito K, Abe Y, Shin RW, Kamitani T, Ueda N (2003) NEDD8 protein is involved in ubiquitinated inclusion bodies. J Pathol 199:259\u2013266","journal-title":"J Pathol"},{"key":"560_CR23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/1098-1004(200007)16:1<89::AID-HUMU18>3.0.CO;2-7","volume":"16","author":"J Dong","year":"2000","unstructured":"Dong J, Gailani MR, Pomeroy SL, Reardon D, Bale AE (2000) Identification of PATCHED mutations in medulloblastomas by direct sequencing. Hum Mutat 16:89\u201390","journal-title":"Hum Mutat"},{"key":"560_CR24","doi-asserted-by":"crossref","unstructured":"Duka T, Duka V, Joyce JN, Sidhu A (2009) \u03b1-Synuclein contributes to GSK-3\u03b2-catalyzed Tau phosphorylation in Parkinson\u2019s disease models. FASEB J (in press)","DOI":"10.1096\/fj.08-120410"},{"issue":"1","key":"560_CR25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.nbd.2009.03.013","volume":"35","author":"J Dusonchet","year":"2009","unstructured":"Dusonchet J, Bensadoun JC, Schneider BL, Aebischer P (2009) Targeted overexpression of the parkin substrate Pael-R in the nigrostriatal system of adult rats to model Parkinson\u2019s disease. Neurobiol Dis 35(1):32\u201341","journal-title":"Neurobiol Dis"},{"key":"560_CR26","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1128\/MCB.25.7.2795-2807.2005","volume":"25","author":"EJ Eide","year":"2005","unstructured":"Eide EJ, Woolf MF, Kang H et al (2005) Control of mammalian circadian rhythm by CKIepsilon-regulated proteasome-mediated PER2 degradation. Mol Cell Biol 25:2795\u20132807","journal-title":"Mol Cell Biol"},{"key":"560_CR27","doi-asserted-by":"crossref","first-page":"8410","DOI":"10.1523\/JNEUROSCI.3622-04.2004","volume":"24","author":"Y Elgersma","year":"2004","unstructured":"Elgersma Y, Sweatt JD, Giese KP (2004) Mouse genetic approaches to investigating calcium\/calmodulin-dependent protein kinase II function in plasticity and cognition. J Neurosci 24:8410\u20138415","journal-title":"J Neurosci"},{"key":"560_CR28","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4161\/auto.5604","volume":"4","author":"S Engelender","year":"2008","unstructured":"Engelender S (2008) Ubiquitination of alpha-synuclein and autophagy in Parkinson\u2019s disease. Autophagy 4:372\u2013374","journal-title":"Autophagy"},{"key":"560_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1145\/1122501.1122502","volume":"25","author":"Z Feng","year":"2006","unstructured":"Feng Z, Jin S, Zupnick A et al (2006) p53 tumor suppressor protein regulates the levels of huntingtin gene expression. Oncogene 25:1\u20137","journal-title":"Oncogene"},{"key":"560_CR30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1100\/tsw.2008.60","volume":"8","author":"S Finkbeiner","year":"2008","unstructured":"Finkbeiner S, Mitra S (2008) The ubiquitin\u2013proteasome pathway in Huntington\u2019s disease. Sci World J 8:421\u2013433","journal-title":"Sci World J"},{"key":"560_CR31","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archneur.65.8.1031","volume":"65","author":"AS Fleisher","year":"2008","unstructured":"Fleisher AS, Raman R, Siemers ER et al (2008) Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease. Arch Neurol 65:1031\u20131038","journal-title":"Arch Neurol"},{"key":"560_CR32","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/j.1471-4159.2004.02987.x","volume":"92","author":"J Fortun","year":"2005","unstructured":"Fortun J, Li J, Go J, Fenstermaker A, Fletcher BS, Notterpek L (2005) Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model. J Neurochem 92:1531\u20131541","journal-title":"J Neurochem"},{"key":"560_CR33","doi-asserted-by":"crossref","first-page":"6002","DOI":"10.1038\/onc.2008.199","volume":"27","author":"M Fujiwara","year":"2008","unstructured":"Fujiwara M, Marusawa H, Wang HQ et al (2008) Parkin as a tumor suppressor gene for hepatocellular carcinoma. Oncogene 27:6002\u20136011","journal-title":"Oncogene"},{"key":"560_CR34","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/jnnp.2006.107904","volume":"78","author":"C Gaig","year":"2007","unstructured":"Gaig C, Marti MJ, Ezquerra M, Rey MJ, Cardozo A, Tolosa E (2007) G2019S LRRK2 mutation causing Parkinson\u2019s disease without Lewy bodies. J Neurol Neurosurg Psychiatry 78:626\u2013628","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"560_CR35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/PAI.0b013e318126bff5","volume":"16","author":"SE Gibson","year":"2008","unstructured":"Gibson SE, Zeng WF, Weil RJ, Prayson RA (2008) Aurora B kinase expression in ependymal neoplasms. Appl Immunohistochem Mol Morphol 16:274\u2013278","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"560_CR36","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nature07953","volume":"459","author":"JT Glessner","year":"2009","unstructured":"Glessner JT, Wang K, Cai G (2009) Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459:569\u2013573","journal-title":"Nature"},{"key":"560_CR37","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1073\/pnas.96.5.2439","volume":"96","author":"JA Golden","year":"1999","unstructured":"Golden JA, Bracilovic A, McFadden KA, Beesley JS, Rubenstein JL, Grinspan JB (1999) Ectopic bone morphogenetic proteins 5 and 4 in the chicken forebrain lead to cyclopia and holoprosencephaly. Proc Natl Acad Sci USA 96:2439\u20132444","journal-title":"Proc Natl Acad Sci USA"},{"key":"560_CR38","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1358\/dnp.2007.20.6.1138160","volume":"20","author":"B Gong","year":"2007","unstructured":"Gong B, Leznik E (2007) The role of ubiquitin C-terminal hydrolase L1 in neurodegenerative disorders. Drug News Perspect 20:365\u2013370","journal-title":"Drug News Perspect"},{"key":"560_CR39","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.4049\/jimmunol.155.8.3750","volume":"155","author":"EP Grant","year":"1995","unstructured":"Grant EP, Michalek MT, Goldberg AL, Rock KL (1995) Rate of antigen degradation by the ubiquitin\u2013proteasome pathway influences MHC class I presentation. J Immunol 155:3750\u20133758","journal-title":"J Immunol"},{"key":"560_CR40","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S1534-5807(03)00154-0","volume":"4","author":"D Guardavaccaro","year":"2003","unstructured":"Guardavaccaro D, Kudo Y, Boulaire J et al (2003) Control of meiotic and mitotic progression by the F box protein beta-Trcp1 in vivo. Dev Cell 4:799\u2013812","journal-title":"Dev Cell"},{"key":"560_CR41","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1016\/S0021-9258(18)34958-5","volume":"257","author":"AL Haas","year":"1982","unstructured":"Haas AL, Warms JV, Hershko A, Rose IA (1982) Ubiquitin-activating enzyme mechanism and role in protein\u2013ubiquitin conjugation. J Biol Chem 257:2543\u20132548","journal-title":"J Biol Chem"},{"key":"560_CR42","first-page":"3940","volume":"117","author":"J Hanai","year":"2007","unstructured":"Hanai J, Cao P, Tanksale P et al (2007) The muscle-specific ubiquitin ligase atrogin-1\/MAFbx mediates statin-induced muscle toxicity. J Clin Invest 117:3940\u20133951","journal-title":"J Clin Invest"},{"key":"560_CR43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0960-9822(99)80091-8","volume":"9","author":"M Hart","year":"1999","unstructured":"Hart M, Concordet JP, Lassot I et al (1999) The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol 9:207\u2013210","journal-title":"Curr Biol"},{"key":"560_CR44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","volume":"67","author":"A Hershko","year":"1998","unstructured":"Hershko A, Ciechanover A (1998) The ubiquitin system. Annu Rev Biochem 67:425\u2013479","journal-title":"Annu Rev Biochem"},{"key":"560_CR45","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1038\/sj.onc.1207407","volume":"23","author":"L Hesson","year":"2004","unstructured":"Hesson L, Bi\u00e8che I, Krex D et al (2004) Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas. Oncogene 23:2408\u20132419","journal-title":"Oncogene"},{"key":"560_CR46","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/nen.0b013e3181567f02","volume":"66","author":"IE Holm","year":"2007","unstructured":"Holm IE, Englund E, Mackenzie IR, Johannsen P, Isaacs AM (2007) A reassessment of the neuropathology of frontotemporal dementia linked to chromosome 3. J Neuropathol Exp Neurol 66:884\u2013891","journal-title":"J Neuropathol Exp Neurol"},{"key":"560_CR47","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1006\/mcne.2002.1103","volume":"20","author":"S Hong","year":"2002","unstructured":"Hong S, Kim SJ, Ka S, Choi I, Kang S (2002) USP7, a ubiquitin-specific protease, interacts with ataxin-1, the SCA1 gene product. Mol Cell Neurosci 20:298\u2013306","journal-title":"Mol Cell Neurosci"},{"key":"560_CR48","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/ncb785","volume":"4","author":"JY Hsu","year":"2002","unstructured":"Hsu JY, Reimann JD, Sorensen CS, Lukas J, Jackson PK (2002) E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APC (Cdh1). Nat Cell Biol 4:358\u2013366","journal-title":"Nat Cell Biol"},{"key":"560_CR49","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00401-008-0446-3","volume":"116","author":"Y Huang","year":"2008","unstructured":"Huang Y, Song YJ, Murphy K et al (2008) LRRK2 and parkin immunoreactivity in multiple system atrophy inclusions. Acta Neuropathol 116:639\u2013646","journal-title":"Acta Neuropathol"},{"key":"560_CR50","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.expneurol.2006.09.009","volume":"203","author":"DP Huynh","year":"2007","unstructured":"Huynh DP, Nguyen DT, Pulst-Korenberg JB, Brice A, Pulst SM (2007) Parkin is an E3 ubiquitin-ligase for normal and mutant ataxin-2 and prevents ataxin-2-induced cell death. Exp Neurol 203:531\u2013541","journal-title":"Exp Neurol"},{"key":"560_CR51","doi-asserted-by":"crossref","first-page":"9796","DOI":"10.1074\/jbc.M809739200","volume":"284","author":"A Iwata","year":"2009","unstructured":"Iwata A, Nagashima Y, Matsumoto L et al (2009) Intranuclear degradation of polyglutamine aggregates by the ubiquitin\u2013proteasome system. J Biol Chem 284:9796\u20139803","journal-title":"J Biol Chem"},{"key":"560_CR52","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1158\/1078-0432.CCR-08-0150","volume":"14","author":"RJ Jones","year":"2008","unstructured":"Jones RJ, Chen Q, Voorhees PM et al (2008) Inhibition of the p53 E3 ligase HDM-2 induces apoptosis and DNA damage-independent p53 phosphorylation in mantle cell lymphoma. Clin Cancer Res 14:5416\u20135425","journal-title":"Clin Cancer Res"},{"key":"560_CR53","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-008-0397-8","volume":"116","author":"KA Josephs","year":"2008","unstructured":"Josephs KA, Lin WL, Ahmed Z, Stroh DA, Graff-Radford NR, Dickson DW (2008) Frontotemporal lobar degeneration with ubiquitin-positive, but TDP-43-negative inclusions. Acta Neuropathol 116:159\u2013167","journal-title":"Acta Neuropathol"},{"key":"560_CR54","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc885","volume":"2","author":"WG Kaelin","year":"2002","unstructured":"Kaelin WG (2002) Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer 2:673\u2013682","journal-title":"Nat Rev Cancer"},{"key":"560_CR55","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jmb.2005.12.001","volume":"356","author":"Y Kang","year":"2006","unstructured":"Kang Y, Vossler RA, Diaz-Martinez LA, Winter NS, Clarke DJ, Walters KJ (2006) UBL\/UBA ubiquitin receptor proteins bind a common tetraubiquitin chain. J Mol Biol 356:1027\u20131035","journal-title":"J Mol Biol"},{"key":"560_CR56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neulet.2007.11.066","volume":"431","author":"TJ Kannanayakal","year":"2008","unstructured":"Kannanayakal TJ, Mendell JR, Kuret J (2008) Casein kinase 1 alpha associates with the tau-bearing lesions of inclusion body myositis. Neurosci Lett 431:141\u2013145","journal-title":"Neurosci Lett"},{"key":"560_CR57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s004010051191","volume":"100","author":"T Kawashima","year":"2000","unstructured":"Kawashima T, Furuta A, Doh-ura K, Kikuchi H, Iwaki T (2000) Ubiquitin-immunoreactive skein-like inclusions in the neostriatum are not restricted to amyotrophic lateral sclerosis, but are rather aging-related structures. Acta Neuropathol 100:43\u201349","journal-title":"Acta Neuropathol"},{"key":"560_CR58","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1091\/mbc.e06-09-0787","volume":"18","author":"BY Kim","year":"2007","unstructured":"Kim BY, Olzmann JA, Barsh GS, Chin LS, Li L (2007) Spongiform neurodegeneration-associated E3 ligase Mahogunin ubiquitylates TSG101 and regulates endosomal trafficking. Mol Biol Cell 18:1129\u20131142","journal-title":"Mol Biol Cell"},{"key":"560_CR59","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1096\/fj.08-113910","volume":"22","author":"MJ Kim","year":"2008","unstructured":"Kim MJ, Chia IV, Costantini F (2008) SUMOylation target sites at the C terminus protect Axin from ubiquitination and confer protein stability. FASEB J 22:3785\u20133794","journal-title":"FASEB J"},{"key":"560_CR60","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1074\/jbc.M808064200","volume":"284","author":"SH Kim","year":"2009","unstructured":"Kim SH, Shi Y, Hanson KA et al (2009) Potentiation of amyotrophic lateral sclerosis (ALS)-associated TDP-43 aggregation by the proteasome-targeting factor, ubiquilin 1. J Biol Chem 284:8083\u20138092","journal-title":"J Biol Chem"},{"key":"560_CR61","doi-asserted-by":"crossref","first-page":"28530","DOI":"10.1074\/jbc.M203372200","volume":"277","author":"A Kinoshita","year":"2002","unstructured":"Kinoshita A, Whelan CM, Berezovska O, Hyman BT (2002) The gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein induces apoptosis via Tip60 in H4 cells. J Biol Chem 277:28530\u201328536","journal-title":"J Biol Chem"},{"key":"560_CR62","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.molcel.2009.04.026","volume":"34","author":"V Kirkin","year":"2009","unstructured":"Kirkin V, McEwan DG, Novak I, Dikic I (2009) A role for ubiquitin in selective autophagy. Mol Cell 34:259\u2013269","journal-title":"Mol Cell"},{"key":"560_CR63","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1073\/pnas.0810123106","volume":"106","author":"HS Ko","year":"2009","unstructured":"Ko HS, Bailey R, Smith WW et al (2009) CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity. Proc Natl Acad Sci USA 106:2897\u20132902","journal-title":"Proc Natl Acad Sci USA"},{"key":"560_CR64","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0092-8674(00)80574-7","volume":"96","author":"M Koegl","year":"1999","unstructured":"Koegl M, Hoppe T, Schlenker S, Ulrich HD, Mayer TU, Jentsch S (1999) A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 96:635\u2013644","journal-title":"Cell"},{"key":"560_CR65","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1126\/science.1065203","volume":"294","author":"DM Koepp","year":"2001","unstructured":"Koepp DM, Schaefer LK, Ye X et al (2001) Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science 294:173\u2013177","journal-title":"Science"},{"key":"560_CR66","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1126\/science.1093712","volume":"303","author":"Y Konishi","year":"2004","unstructured":"Konishi Y, Stegm\u00fcller J, Matsuda T, Bonni S, Bonni A (2004) Cdh1-APC controls axonal growth and patterning in the mammalian brain. Science 303:1026\u20131030","journal-title":"Science"},{"key":"560_CR67","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0962-8924(00)01852-3","volume":"10","author":"RR Kopito","year":"2000","unstructured":"Kopito RR (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 10:524\u2013530","journal-title":"Trends Cell Biol"},{"key":"560_CR68","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.molcel.2007.04.001","volume":"26","author":"M Kristiansen","year":"2007","unstructured":"Kristiansen M, Deriziotis P, Dimcheff DE et al (2007) Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol Cell 26:175\u2013188","journal-title":"Mol Cell"},{"key":"560_CR69","doi-asserted-by":"crossref","first-page":"38851","DOI":"10.1074\/jbc.M506600200","volume":"280","author":"M Kristiansen","year":"2005","unstructured":"Kristiansen M, Messenger MJ, Klohn PC et al (2005) Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis. J Biol Chem 280:38851\u201338861","journal-title":"J Biol Chem"},{"key":"560_CR70","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cell.2009.04.050","volume":"137","author":"JP Kruse","year":"2009","unstructured":"Kruse JP, Gu W (2009) Modes of p53 regulation. Cell 137:609\u2013622","journal-title":"Cell"},{"key":"560_CR71","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1074\/jbc.M805658200","volume":"284","author":"JP Kruse","year":"2009","unstructured":"Kruse JP, Gu W (2009) MSL2 promotes Mdm2-independent cytoplasmic localization of p53. J Biol Chem 284:3250\u20133263","journal-title":"J Biol Chem"},{"key":"560_CR72","doi-asserted-by":"crossref","first-page":"e4973","DOI":"10.1371\/journal.pone.0004973","volume":"4","author":"J Lagirand-Cantaloube","year":"2009","unstructured":"Lagirand-Cantaloube J, Cornille K, Csibi A, Batonnet-Pichon S, Leibovitch MP, Leibovitch SA (2009) Inhibition of atrogin-1\/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo. PLoS ONE 4:e4973","journal-title":"PLoS ONE"},{"key":"560_CR73","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1471-4159.2008.05715.x","volume":"107","author":"JD Lathia","year":"2008","unstructured":"Lathia JD, Mattson MP, Cheng A (2008) Notch: from neural development to neurological disorders. J Neurochem 107:1471\u20131481","journal-title":"J Neurochem"},{"key":"560_CR74","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/hmg\/10.11.1201","volume":"10","author":"AS Lebre","year":"2001","unstructured":"Lebre AS, Jamot L, Takahashi J et al (2001) Ataxin-7 interacts with a Cbl-associated protein that it recruits into neuronal intranuclear inclusions. Hum Mol Genet 10:1201\u20131213","journal-title":"Hum Mol Genet"},{"key":"560_CR75","first-page":"906","volume":"17","author":"JT Lee","year":"2008","unstructured":"Lee JT, Wheeler TC, Li L, Chin LS (2008) Ubiquitination of alpha-synuclein by Siah-1 promotes alpha-synuclein aggregation and apoptotic cell death. Hum Mol Genet 17:906\u2013917","journal-title":"Hum Mol Genet"},{"key":"560_CR76","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s002800050022","volume":"45","author":"NL Lehman","year":"2000","unstructured":"Lehman NL, Danenberg PV (2000) Modulation of RTX cytotoxicity by thymidine and dipyridamole in vitro: implications for chemotherapy. Cancer Chemother Pharmacol 45:142\u2013148","journal-title":"Cancer Chemother Pharmacol"},{"key":"560_CR77","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.2353\/ajpath.2007.060767","volume":"170","author":"NL Lehman","year":"2007","unstructured":"Lehman NL, Tibshirani R, Hsu JY et al (2007) Oncogenic regulators and substrates of the anaphase promoting complex\/cyclosome are frequently overexpressed in malignant tumors. Am J Pathol 170:1793\u20131805","journal-title":"Am J Pathol"},{"key":"560_CR78","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0076-6879(05)99023-X","volume":"399","author":"NL Lehman","year":"2005","unstructured":"Lehman NL, van de Rijn M, Jackson PK (2005) Screening of tissue microarrays for ubiquitin proteasome system components in tumors. Methods Enzymol 399:334\u2013355","journal-title":"Methods Enzymol"},{"key":"560_CR79","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.4161\/cc.5.14.2925","volume":"5","author":"NL Lehman","year":"2006","unstructured":"Lehman NL, Verschuren EW, Hsu JY, Cherry AM, Jackson PK (2006) Overexpression of the anaphase promoting complex\/cyclosome inhibitor Emi1 leads to tetraploidy and genomic instability of p53-deficient cells. Cell Cycle 5:1569\u20131573","journal-title":"Cell Cycle"},{"key":"560_CR80","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1073\/pnas.0401081101","volume":"101","author":"E Liani","year":"2004","unstructured":"Liani E, Eyal A, Avraham E et al (2004) Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson\u2019s disease. Proc Natl Acad Sci USA 101:5500\u20135505","journal-title":"Proc Natl Acad Sci USA"},{"key":"560_CR81","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1468-1331.2008.02195.x","volume":"15","author":"RM Liscic","year":"2008","unstructured":"Liscic RM, Grinberg LT, Zidar J, Gitcho MA, Cairns NJ (2008) ALS and FTLD: two faces of TDP-43 proteinopathy. Eur J Neurol 15:772\u2013780","journal-title":"Eur J Neurol"},{"key":"560_CR82","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1111\/j.1460-9568.2008.06497.x","volume":"28","author":"S Liu","year":"2008","unstructured":"Liu S, Bromley-Brits K, Xia K, Mittelholtz J, Wang R, Song W (2008) TMP21 degradation is mediated by the ubiquitin\u2013proteasome pathway. Eur J Neurosci 28:1980\u20131988","journal-title":"Eur J Neurosci"},{"key":"560_CR83","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.immunol.22.012703.104813","volume":"22","author":"YC Liu","year":"2004","unstructured":"Liu YC (2004) Ubiquitin ligases and the immune response. Annu Rev Immunol 22:81\u2013127","journal-title":"Annu Rev Immunol"},{"key":"560_CR84","doi-asserted-by":"crossref","first-page":"e1000383","DOI":"10.1371\/journal.pgen.1000383","volume":"5","author":"SE Lloyd","year":"2009","unstructured":"Lloyd SE, Maytham EG, Pota H et al (2009) HECTD2 is associated with susceptibility to mouse and human prion disease. PLoS Genet 5:e1000383","journal-title":"PLoS Genet"},{"key":"560_CR85","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1101\/gad.1461306","volume":"20","author":"X Lu","year":"2006","unstructured":"Lu X, Liu S, Kornberg TB (2006) The C-terminal tail of the Hedgehog receptor Patched regulates both localization and turnover. Genes Dev 20:2539\u20132551","journal-title":"Genes Dev"},{"key":"560_CR86","first-page":"5906","volume":"62","author":"ME Lusher","year":"2002","unstructured":"Lusher ME, Lindsey JC, Latif F, Pearson AD, Ellison DW, Clifford SC (2002) Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development. Cancer Res 62:5906\u20135911","journal-title":"Cancer Res"},{"key":"560_CR87","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.21147","volume":"61","author":"IR Mackenzie","year":"2007","unstructured":"Mackenzie IR, Bigio EH, Ince PG et al (2007) Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 61:427\u2013434","journal-title":"Ann Neurol"},{"key":"560_CR88","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/hmg\/ddi097","volume":"14","author":"K Makedonski","year":"2005","unstructured":"Makedonski K, Abuhatzira L, Kaufman Y, Razin A, Shemer R (2005) MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS\/AS imprinting center that affects UBE3A expression. Hum Mol Genet 14:1049\u20131058","journal-title":"Hum Mol Genet"},{"key":"560_CR89","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1073\/pnas.0608798104","volume":"104","author":"MG Manfredi","year":"2007","unstructured":"Manfredi MG, Ecsedy JA, Meetze KA et al (2007) Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase. Proc Natl Acad Sci USA 104:4106\u20134111","journal-title":"Proc Natl Acad Sci USA"},{"key":"560_CR90","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1074\/jbc.M108302200","volume":"277","author":"LD Mayo","year":"2002","unstructured":"Mayo LD, Dixon JE, Durden DL, Tonks NK, Donner DB (2002) PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. J Biol Chem 277:5484\u20135489","journal-title":"J Biol Chem"},{"key":"560_CR91","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00401-008-0439-2","volume":"116","author":"J Miklossy","year":"2008","unstructured":"Miklossy J, Steele JC, Yu S et al (2008) Enduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis\/parkinsonism-dementia complex of Guam (ALS\/PDC). Acta Neuropathol 116:625\u2013637","journal-title":"Acta Neuropathol"},{"key":"560_CR92","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cancergencyto.2005.09.004","volume":"166","author":"MB Michalowski","year":"2006","unstructured":"Michalowski MB, de Fraipont F, Michelland S et al (2006) Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma. Cancer Genet Cytogenet 166:74\u201381","journal-title":"Cancer Genet Cytogenet"},{"key":"560_CR93","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1101\/gad.1454006","volume":"20","author":"JJ Miller","year":"2006","unstructured":"Miller JJ, Summers MK, Hansen DV et al (2006) Emi1 stably binds and inhibits the anaphase-promoting complex\/cyclosome as a pseudosubstrate inhibitor. Genes Dev 20:2410\u20132420","journal-title":"Genes Dev"},{"key":"560_CR94","doi-asserted-by":"crossref","first-page":"7648","DOI":"10.1074\/jbc.M706620200","volume":"283","author":"A Mishra","year":"2008","unstructured":"Mishra A, Dikshit P, Purkayastha S, Sharma J, Nukina N, Jana NR (2008) E6-AP promotes misfolded polyglutamine proteins for proteasomal degradation and suppresses polyglutamine protein aggregation and toxicity. J Biol Chem 283:7648\u20137656","journal-title":"J Biol Chem"},{"key":"560_CR95","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1093\/hmg\/ddn296","volume":"17","author":"Y Morishima","year":"2008","unstructured":"Morishima Y, Wang AM, Yu Z, Pratt WB, Osawa Y, Lieberman AP (2008) CHIP deletion reveals functional redundancy of E3 ligases in promoting degradation of both signaling proteins and expanded glutamine proteins. Hum Mol Genet 17:3942\u20133952","journal-title":"Hum Mol Genet"},{"key":"560_CR96","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1742-4658.2008.06858.x","volume":"276","author":"G Morreale","year":"2009","unstructured":"Morreale G, Conforti L, Coadwell J, Wilbrey AL, Coleman MP (2009) Evolutionary divergence of valosin-containing protein\/cell division cycle protein 48 binding interactions among endoplasmic reticulum-associated degradation proteins. FEBS J 276:1208\u20131220","journal-title":"FEBS J"},{"key":"560_CR97","doi-asserted-by":"crossref","first-page":"21323","DOI":"10.1074\/jbc.C300096200","volume":"278","author":"Y Mosesson","year":"2003","unstructured":"Mosesson Y, Shtiegman K, Katz M et al (2003) Endocytosis of receptor tyrosine kinases is driven by monoubiquitylation, not polyubiquitylation. J Biol Chem 278:21323\u201321326","journal-title":"J Biol Chem"},{"key":"560_CR98","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/emboj\/17.1.61","volume":"17","author":"S Muller","year":"1998","unstructured":"Muller S, Matunis MJ, Dejean A (1998) Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J 17:61\u201370","journal-title":"EMBO J"},{"key":"560_CR99","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1091\/mbc.e02-07-0441","volume":"14","author":"G Murakami","year":"2003","unstructured":"Murakami G, Watabe T, Takaoka K, Miyazono K, Imamura T (2003) Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Mol Biol Cell 14:2809\u20132817","journal-title":"Mol Biol Cell"},{"key":"560_CR100","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1158\/0008-5472.CAN-03-3968","volume":"64","author":"K Neben","year":"2004","unstructured":"Neben K, Korshunov A, Benner A et al (2004) Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival. Cancer Res 64:3103\u20133111","journal-title":"Cancer Res"},{"key":"560_CR101","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/nen.0b013e31803020b9","volume":"66","author":"M Neumann","year":"2007","unstructured":"Neumann M, Mackenzie IR, Cairns NJ et al (2007) TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. J Neuropathol Exp Neurol 66:152\u2013157","journal-title":"J Neuropathol Exp Neurol"},{"key":"560_CR102","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.cellsig.2008.05.018","volume":"20","author":"D Nonis","year":"2008","unstructured":"Nonis D, Schmidt MH, van de Loo S et al (2008) Ataxin-2 associates with the endocytosis complex and affects EGF receptor trafficking. Cell Signal 20:1725\u20131739","journal-title":"Cell Signal"},{"key":"560_CR103","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1212\/01.wnl.0000231510.89311.8b","volume":"67","author":"N Parkinson","year":"2006","unstructured":"Parkinson N, Ince PG, Smith MO et al (2006) ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology 67:1074\u20131077","journal-title":"Neurology"},{"key":"560_CR104","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1471-4159.2008.05340.x","volume":"106","author":"J Ramesh Babu","year":"2008","unstructured":"Ramesh Babu J, Lamar Seibenhener M, Peng J et al (2008) Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration. J Neurochem 106:107\u2013120","journal-title":"J Neurochem"},{"key":"560_CR105","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0092-8674(01)00361-0","volume":"105","author":"JD Reimann","year":"2001","unstructured":"Reimann JD, Freed E, Hsu JY, Kramer ER, Peters JM, Jackson PK (2001) Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex. Cell 105:645\u2013655","journal-title":"Cell"},{"key":"560_CR106","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1182\/blood-2006-08-036947","volume":"110","author":"PG Richardson","year":"2007","unstructured":"Richardson PG, Sonneveld P, Schuster M et al (2007) Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial. Blood 110:3557\u20133560","journal-title":"Blood"},{"key":"560_CR107","doi-asserted-by":"crossref","first-page":"42290","DOI":"10.1074\/jbc.M406284200","volume":"279","author":"BE Riley","year":"2004","unstructured":"Riley BE, Xu Y, Zoghbi HY, Orr HT (2004) The effects of the polyglutamine repeat protein ataxin-1 on the UbL-UBA protein A1Up. J Biol Chem 279:42290\u201342301","journal-title":"J Biol Chem"},{"key":"560_CR108","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00401-008-0395-x","volume":"116","author":"S Roeber","year":"2008","unstructured":"Roeber S, Mackenzie IR, Kretzschmar HA, Neumann M (2008) TDP-43-negative FTLD-U is a significant new clinico-pathological subtype of FTLD. Acta Neuropathol 116:147\u2013157","journal-title":"Acta Neuropathol"},{"key":"560_CR109","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1074\/jbc.M704809200","volume":"283","author":"R Rott","year":"2008","unstructured":"Rott R, Szargel R, Haskin J et al (2008) Monoubiquitylation of alpha-synuclein by seven in absentia homolog (SIAH) promotes its aggregation in dopaminergic cells. J Biol Chem 283:3316\u20133328","journal-title":"J Biol Chem"},{"key":"560_CR110","doi-asserted-by":"crossref","first-page":"15690","DOI":"10.1073\/pnas.0808373105","volume":"105","author":"R Sadeh","year":"2008","unstructured":"Sadeh R, Breitschopf K, Bercovich B et al (2008) The N-terminal domain of MyoD is necessary and sufficient for its nuclear localization-dependent degradation by the ubiquitin system. Proc Natl Acad Sci USA 105:15690\u201315695","journal-title":"Proc Natl Acad Sci USA"},{"key":"560_CR111","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1177\/0883073808316367","volume":"23","author":"S Sartori","year":"2008","unstructured":"Sartori S, Anesi L, Polli R et al (2008) Angelman syndrome due to a novel splicing mutation of the UBE3A gene. J Child Neurol 23:912\u2013915","journal-title":"J Child Neurol"},{"key":"560_CR112","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1074\/mcp.M800025-MCP200","volume":"7","author":"J Schimmel","year":"2008","unstructured":"Schimmel J, Larsen KM, Matic I et al (2008) The ubiquitin\u2013proteasome system is a key component of the SUMO-2\/3 cycle. Mol Cell Proteomics 7:2107\u20132122","journal-title":"Mol Cell Proteomics"},{"key":"560_CR113","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev.pharmtox.051208.165340","volume":"49","author":"AL Schwartz","year":"2009","unstructured":"Schwartz AL, Ciechanover A (2009) Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. Annu Rev Pharmacol Toxicol 49:73\u201396","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"560_CR114","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/S0002-9440(10)64477-X","volume":"161","author":"S Sekine","year":"2002","unstructured":"Sekine S, Shibata T, Kokubu A et al (2002) Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations. Am J Pathol 161:1997\u20132001","journal-title":"Am J Pathol"},{"key":"560_CR115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuint.2007.05.007","volume":"51","author":"R Setsuie","year":"2007","unstructured":"Setsuie R, Wada K (2007) The functions of UCH-L1 and its relation to neurodegenerative diseases. Neurochem Int 51:105\u2013111","journal-title":"Neurochem Int"},{"key":"560_CR116","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/nsmb.1521","volume":"15","author":"Y Sheng","year":"2008","unstructured":"Sheng Y, Laister RC, Lemak A et al (2008) Molecular basis of Pirh2-mediated p53 ubiquitylation. Nat Struct Mol Biol 15:1334\u20131342","journal-title":"Nat Struct Mol Biol"},{"key":"560_CR117","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bbrc.2009.04.006","volume":"383","author":"K Shiba","year":"2009","unstructured":"Shiba K, Arai T, Sato S et al (2009) Parkin stabilizes PINK1 through direct interaction. Biochem Biophys Res Commun 383:331\u2013335","journal-title":"Biochem Biophys Res Commun"},{"key":"560_CR118","doi-asserted-by":"crossref","first-page":"14889","DOI":"10.1021\/bi700499j","volume":"46","author":"C Song","year":"2007","unstructured":"Song C, Wang Q, Li CC (2007) Characterization of the aggregation-prevention activity of p97\/valosin-containing protein. Biochemistry 46:14889\u201314898","journal-title":"Biochemistry"},{"key":"560_CR119","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1158\/0008-5472.CAN-08-3984","volume":"69","author":"SJ Song","year":"2009","unstructured":"Song SJ, Song MS, Kim SJ et al (2009) Aurora A regulates prometaphase progression by inhibiting the ability of RASSF1A to suppress APC-Cdc20 activity. Cancer Res 69:2314\u20132323","journal-title":"Cancer Res"},{"key":"560_CR120","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0896-6273(03)00084-9","volume":"37","author":"JF Staropoli","year":"2003","unstructured":"Staropoli JF, McDermott C, Martinat C, Schulman B, Demireva E, Abeliovich A (2003) Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron 37:735\u2013749","journal-title":"Neuron"},{"key":"560_CR121","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.nbd.2005.04.018","volume":"20","author":"AL Str\u00f6m","year":"2005","unstructured":"Str\u00f6m AL, Forsgren L, Holmberg M (2005) A role for both wild-type and expanded ataxin-7 in transcriptional regulation. Neurobiol Dis 20:646\u2013655","journal-title":"Neurobiol Dis"},{"key":"560_CR122","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nrn2499","volume":"9","author":"HC Tai","year":"2008","unstructured":"Tai HC, Schuman EM (2008) Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction. Nat Rev Neurosci 9:826\u2013838","journal-title":"Nat Rev Neurosci"},{"key":"560_CR123","doi-asserted-by":"crossref","unstructured":"Tan JM, Wong ES, Dawson VL, Dawson TM, Lim KL (2007) Lysine 63-linked polyubiquitin potentially partners with p62 to promote the clearance of protein inclusions by autophagy. Autophagy 4(2) (in press)","DOI":"10.4161\/auto.5444"},{"key":"560_CR124","doi-asserted-by":"crossref","first-page":"e1000382","DOI":"10.1371\/journal.pgen.1000382","volume":"5","author":"EM Tank","year":"2009","unstructured":"Tank EM, True HL (2009) Disease-associated mutant ubiquitin causes proteasomal impairment and enhances the toxicity of protein aggregates. PLoS Genet 5:e1000382","journal-title":"PLoS Genet"},{"key":"560_CR125","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/emboj.2008.289","volume":"28","author":"SV Todi","year":"2009","unstructured":"Todi SV, Winborn BJ, Scaglione KM, Blount JR, Travis SM, Paulson HL (2009) Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3. EMBO J 28:372\u2013382","journal-title":"EMBO J"},{"key":"560_CR126","doi-asserted-by":"crossref","unstructured":"Tortosa E, Santa-Maria I, Moreno F, Lim F, Perez M, Avila J (2009) Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein. J Alzheimers Dis (in press)","DOI":"10.3233\/JAD-2009-1049"},{"key":"560_CR127","doi-asserted-by":"crossref","first-page":"13285","DOI":"10.1523\/JNEUROSCI.4393-08.2008","volume":"28","author":"S Tydlacka","year":"2008","unstructured":"Tydlacka S, Wang CE, Wang X, Li S, Li XJ (2008) Differential activities of the ubiquitin\u2013proteasome system in neurons versus glia may account for the preferential accumulation of misfolded proteins in neurons. J Neurosci 28:13285\u201313295","journal-title":"J Neurosci"},{"key":"560_CR128","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1158\/1535-7163.MCT-08-0754","volume":"8","author":"EC VanderPorten","year":"2009","unstructured":"VanderPorten EC, Taverna P, Hogan JN, Ballinger MD, Flanagan WM, Fucini RV (2009) The Aurora kinase inhibitor SNS-314 shows broad therapeutic potential with chemotherapeutics and synergy with microtubule-targeted agents in a colon carcinoma model. Mol Cancer Ther 8:930\u2013939","journal-title":"Mol Cancer Ther"},{"key":"560_CR129","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1128\/MCB.00350-08","volume":"28","author":"B Varghese","year":"2008","unstructured":"Varghese B, Barriere H, Carbone CJ et al (2008) Polyubiquitination of prolactin receptor stimulates its internalization, postinternalization sorting, and degradation via the lysosomal pathway. Mol Cell Biol 28:5275\u20135287","journal-title":"Mol Cell Biol"},{"key":"560_CR130","doi-asserted-by":"crossref","first-page":"7955","DOI":"10.1128\/MCB.00908-07","volume":"27","author":"EW Verschuren","year":"2007","unstructured":"Verschuren EW, Ban KH, Masek MA, Lehman NL, Jackson PK (2007) Loss of Emi1-dependent anaphase-promoting complex\/cyclosome inhibition deregulates E2F target expression and elicits DNA damage-induced senescence. Mol Cell Biol 27:7955\u20137965","journal-title":"Mol Cell Biol"},{"key":"560_CR131","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1747-1028-3-8","volume":"3","author":"JH Vissers","year":"2008","unstructured":"Vissers JH, Nicassio F, van Lohuizen M, Di Fiore PP, Citterio E (2008) The many faces of ubiquitinated histone H2A: insights from the DUBs. Cell Div 3:8","journal-title":"Cell Div"},{"key":"560_CR132","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cellsig.2006.08.006","volume":"19","author":"HL Wang","year":"2007","unstructured":"Wang HL, He CY, Chou AH, Yeh TH, Chen YL, Li AH (2007) Polyglutamine-expanded ataxin-7 decreases nuclear translocation of NF-kappaB p65 and impairs NF-kappaB activity by inhibiting proteasome activity of cerebellar neurons. Cell Signal 19:573\u2013581","journal-title":"Cell Signal"},{"key":"560_CR133","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1083\/jcb.200709080","volume":"180","author":"J Wang","year":"2008","unstructured":"Wang J, Wang CE, Orr A, Tydlacka S, Li SH, Li XJ (2008) Impaired ubiquitin\u2013proteasome system activity in the synapses of Huntington\u2019s disease mice. J Cell Biol 180:1177\u20131189","journal-title":"J Cell Biol"},{"key":"560_CR134","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/jnnp.2007.131334","volume":"79","author":"CC Weihl","year":"2008","unstructured":"Weihl CC, Temiz P, Miller SE et al (2008) TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry 79:1186\u20131189","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"560_CR135","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/0192623307311412","volume":"36","author":"FR Westwood","year":"2008","unstructured":"Westwood FR, Scott RC, Marsden AM, Bigley A, Randall K (2008) Rosuvastatin: characterization of induced myopathy in the rat. Toxicol Pathol 36:345\u2013352","journal-title":"Toxicol Pathol"},{"key":"560_CR136","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0070-2153(06)76003-3","volume":"76","author":"A Williams","year":"2006","unstructured":"Williams A, Jahreiss L, Sarkar S et al (2006) Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications. Curr Top Dev Biol 76:89\u2013101","journal-title":"Curr Top Dev Biol"},{"key":"560_CR137","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1091\/mbc.e06-05-0432","volume":"17","author":"C Wojcik","year":"2006","unstructured":"Wojcik C, Rowicka M, Kudlicki A et al (2006) Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin\u2013fusion degradation pathway substrates in mammalian cells. Mol Biol Cell 17:4606\u20134618","journal-title":"Mol Biol Cell"},{"key":"560_CR138","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1242\/jcs.00841","volume":"117","author":"C Wojcik","year":"2004","unstructured":"Wojcik C, Yano M, DeMartino GN (2004) RNA interference of valosin-containing protein (VCP\/p97) reveals multiple cellular roles linked to ubiquitin\/proteasome-dependent proteolysis. J Cell Sci 117:281\u2013292","journal-title":"J Cell Sci"},{"key":"560_CR139","doi-asserted-by":"crossref","first-page":"12876","DOI":"10.1074\/jbc.M311652200","volume":"279","author":"GT Wong","year":"2004","unstructured":"Wong GT, Manfra D, Poulet FM et al (2004) Chronic treatment with the gamma-secretase inhibitor LY-411, 575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. J Biol Chem 279:12876\u201312882","journal-title":"J Biol Chem"},{"key":"560_CR140","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1093\/hmg\/ddn218","volume":"17","author":"HK Wong","year":"2008","unstructured":"Wong HK, Bauer PO, Kurosawa M et al (2008) Blocking acid-sensing ion channel 1 alleviates Huntington\u2019s disease pathology via an ubiquitin\u2013proteasome system-dependent mechanism. Hum Mol Genet 17:3223\u20133235","journal-title":"Hum Mol Genet"},{"key":"560_CR141","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1073\/pnas.0812256106","volume":"106","author":"Y Xia","year":"2009","unstructured":"Xia Y, Padre RC, De Mendoza TH, Bottero V, Tergaonkar VB, Verma IM (2009) Phosphorylation of p53 by IkappaB kinase 2 promotes its degradation by beta-TrCP. Proc Natl Acad Sci USA 106:2629\u20132634","journal-title":"Proc Natl Acad Sci USA"},{"key":"560_CR142","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1172\/JCI37617","volume":"119","author":"H Xiong","year":"2009","unstructured":"Xiong H, Wang D, Chen L et al (2009) Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation. J Clin Invest 119:650\u2013660","journal-title":"J Clin Invest"},{"key":"560_CR143","doi-asserted-by":"crossref","first-page":"16041","DOI":"10.1073\/pnas.2635267100","volume":"100","author":"K Yamanaka","year":"2003","unstructured":"Yamanaka K, Vande Velde C, Eymard-Pierre E, Bertini E, Boespflug-Tanguy O, Cleveland DW (2003) Unstable mutants in the peripheral endosomal membrane component ALS2 cause early-onset motor neuron disease. Proc Natl Acad Sci USA 100:16041\u201316046","journal-title":"Proc Natl Acad Sci USA"},{"key":"560_CR144","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1084\/jem.183.4.1545","volume":"183","author":"B Yang","year":"1996","unstructured":"Yang B, Hahn YS, Hahn CS, Braciale TJ (1996) The requirement for proteasome activity class I major histocompatibility complex antigen presentation is dictated by the length of preprocessed antigen. J Exp Med 183:1545\u20131552","journal-title":"J Exp Med"},{"key":"560_CR145","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00018-007-6396-4","volume":"64","author":"Y Yang","year":"2007","unstructured":"Yang Y, Allen E, Ding J, Wang W (2007) Giant axonal neuropathy. Cell Mol Life Sci 64:601\u2013609","journal-title":"Cell Mol Life Sci"},{"key":"560_CR146","doi-asserted-by":"crossref","unstructured":"Yashiro K, Riday TT, Condon KH et al (2009) Ube3a is required for experience-dependent maturation of the neocortex. Nat Neurosci (in press)","DOI":"10.1038\/nn.2327"},{"key":"560_CR147","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.neuron.2005.07.008","volume":"47","author":"JJ Yi","year":"2005","unstructured":"Yi JJ, Ehlers MD (2005) Ubiquitin and protein turnover in synapse function. Neuron 47:629\u2013632","journal-title":"Neuron"},{"key":"560_CR148","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0896-6273(03)00429-X","volume":"39","author":"Q Zhai","year":"2003","unstructured":"Zhai Q, Wang J, Kim A et al (2003) Involvement of the ubiquitin\u2013proteasome system in the early stages of wallerian degeneration. Neuron 39:217\u2013225","journal-title":"Neuron"},{"key":"560_CR149","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P et al (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44:601\u2013607","journal-title":"Neuron"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-009-0560-x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T05:55:58Z","timestamp":1710482158000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-009-0560-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,14]]},"references-count":149,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["560"],"URL":"https:\/\/doi.org\/10.1007\/s00401-009-0560-x","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,14]]}}}